tiprankstipranks
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market

Sinovac Biotech (SVA) Income Statement

Compare
115 Followers

Sinovac Biotech Income Statement

Last quarter (Q1 2024), Sinovac Biotech's total revenue was $307.87M, a decrease of -96.33% from the same quarter last year. In Q1, Sinovac Biotech's net income was $-116.84M. See Sinovac Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 448.27M$ 1.49B$ 19.37B$ 510.62M$ 246.05M
Gross Profit
$ 266.75M$ 808.30M$ 18.30B$ 443.44M$ 213.58M
Operating Expenses
$ 813.48M$ 1.27B$ 748.45M$ 227.64M$ 144.73M
Depreciation and Amortization
$ 144.75M$ 156.60M$ 100.43M$ 6.63M$ 8.02M
EBITDA
$ -6.03M$ 183.10M$ 17.65B$ 221.76M$ 76.05M
Operating Income
$ -546.72M$ -466.07M$ 17.55B$ 215.64M$ 68.56M
Other Income/Expenses
$ 393.69M$ 491.31M$ 9.78M$ 973.00K$ 2.26M
Pretax Income
$ -153.03M$ 25.24M$ 17.56B$ 216.62M$ 70.82M
Net Income
$ -99.92M$ 113.87M$ 8.47B$ 110.37M$ 44.93M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.06$ 1.08$ 85.20$ 1.06$ 0.42
Diluted EPS
$ -1.06$ 1.00$ 74.27$ 0.97$ 0.41
Weighted Average Shares Outstanding
99.61M 99.50M 99.31M 98.90M 94.88M
Weighted Average Shares Outstanding (Diluted)
99.61M 114.17M 114.01M 113.66M 109.69M
Currency in USD

Sinovac Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis